Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc.（OCUL）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
ocul · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 19 位华尔街分析师
Buy
19 位分析师
共识
评级分布
12 个月目标价
High
$30.00
Consensus
$30.00
+265.9% upside
Low
$30.00
Median: $30 · Last Close: $8.20
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.02 | ↓ 2.15% |
1-day model range: $7.97–$8.07. Peak: $8.07 (-2.15%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $7 | -14.0% |
| 2028 | $7 | -20.6% |
| 2029 | $6 | -23.9% |
| 2030 | $6 | -25.7% |
| 2031 | — | -26.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OCUL · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-05 | Needham | Maintains | Buy→Buy |
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-03 | Clear Street | Maintains | Buy→Buy |
| 2026-02-20 | Needham | Maintains | Buy→Buy |
| 2026-02-18 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-09 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-08 | Needham | Maintains | Buy→Buy |
| 2025-11-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Ocular Therapeutix, Inc. (OCUL) stock. Of the recent 86 rating actions, 6 were upgrades and 5 were downgrades. 19 analysts currently cover OCUL.
分析师推荐趋势
OCUL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$52M
↓ 79.7% YoY
Revenue Next Year
$111M
↑ 113.7% YoY
EPS This Year
$-1.55
EPS Next Year
$-1.45
↓ 6.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast OCUL EPS of $-1.55 for the current fiscal year, based on estimates from 6 analysts. The OCUL revenue forecast is $52M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
OCUL 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。OCUL 的共识目标价为 $30.00（+265.9% 上行空间），分析师共识为 Buy。
OCUL 的短期预测（明日）为 $8.02（-2.15%）。 OCUL 对 2027 年的股价预测均值为 $7。 OCUL 对 2030 年的预测区间为 $6–$7。
Ocular Therapeutix, Inc. 在 NASDAQ 上市，代码 OCUL。OCUL 在 2027 年的整体展望偏积极，在覆盖分析师中约 89% 对应 Buy 共识。
常见问题
OCUL 预测 · 8 个问题根据 19 位华尔街分析师，OCUL 的 12 个月平均目标价为 $30.00，最高 $30.00、最低 $30.00。若有图表，中位目标价可在上方查看。相对当前价 $8.20，隐含约 +265.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.